IOBCF Quote, Financials, Valuation and Earnings

Celyad Oncology SA has a net margin of -- compared to Ion Beam Applications SA's net margin of --. Ion Beam Applications SA's return on equity of 8.22% beat Celyad Oncology SA's return on equity of --.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Celyad Oncology SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Ion Beam Applications SA has higher upside potential than Celyad Oncology SA, analysts believe Ion Beam Applications SA is more attractive than Celyad Oncology SA.

Ion Beam Applications SA has a beta of 1.153, which suggesting that the stock is 15.339% more volatile than S&P 500. In comparison Celyad Oncology SA has a beta of 0.181, suggesting its less volatile than the S&P 500 by 81.876%.

Ion Beam Applications SA has a quarterly dividend of $0.28 per share corresponding to a yield of 1.52%. Celyad Oncology SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ion Beam Applications SA pays 53.12% of its earnings as a dividend. Celyad Oncology SA pays out -- of its earnings as a dividend. Ion Beam Applications SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ion Beam Applications SA quarterly revenues are --, which are smaller than Celyad Oncology SA quarterly revenues of --. Ion Beam Applications SA's net income of -- is lower than Celyad Oncology SA's net income of --. Notably, Ion Beam Applications SA's price-to-earnings ratio is 24.33x while Celyad Oncology SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.82x versus 30.84x for Celyad Oncology SA. Usually stocks with elevated PS ratios are considered overvalued.

Galapagos NV has a net margin of -- compared to Ion Beam Applications SA's net margin of -286.67%. Ion Beam Applications SA's return on equity of 8.22% beat Galapagos NV's return on equity of -16.48%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Galapagos NV has an analysts' consensus of $27.34 which suggests that it could fall by -18.17%. Given that Galapagos NV has higher upside potential than Ion Beam Applications SA, analysts believe Galapagos NV is more attractive than Ion Beam Applications SA.

Ion Beam Applications SA has a beta of 1.153, which suggesting that the stock is 15.339% more volatile than S&P 500. In comparison Galapagos NV has a beta of 0.236, suggesting its less volatile than the S&P 500 by 76.408%.

Ion Beam Applications SA has a quarterly dividend of $0.28 per share corresponding to a yield of 1.52%. Galapagos NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ion Beam Applications SA pays 53.12% of its earnings as a dividend. Galapagos NV pays out -- of its earnings as a dividend. Ion Beam Applications SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ion Beam Applications SA quarterly revenues are --, which are smaller than Galapagos NV quarterly revenues of $83.2M. Ion Beam Applications SA's net income of -- is lower than Galapagos NV's net income of -$238.4M. Notably, Ion Beam Applications SA's price-to-earnings ratio is 24.33x while Galapagos NV's PE ratio is 21.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.82x versus 7.03x for Galapagos NV. Usually stocks with elevated PS ratios are considered overvalued.

UCB SA has a net margin of -- compared to Ion Beam Applications SA's net margin of --. Ion Beam Applications SA's return on equity of 8.22% beat UCB SA's return on equity of 13.88%.

Ion Beam Applications SA has a consensus price target of --, signalling downside risk potential of --. On the other hand UCB SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Ion Beam Applications SA has higher upside potential than UCB SA, analysts believe Ion Beam Applications SA is more attractive than UCB SA.

Ion Beam Applications SA has a beta of 1.153, which suggesting that the stock is 15.339% more volatile than S&P 500. In comparison UCB SA has a beta of 0.678, suggesting its less volatile than the S&P 500 by 32.194%.

Ion Beam Applications SA has a quarterly dividend of $0.28 per share corresponding to a yield of 1.52%. UCB SA offers a yield of 0.49% to investors and pays a quarterly dividend of $0.79 per share. Ion Beam Applications SA pays 53.12% of its earnings as a dividend. UCB SA pays out 15.96% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ion Beam Applications SA quarterly revenues are --, which are smaller than UCB SA quarterly revenues of --. Ion Beam Applications SA's net income of -- is lower than UCB SA's net income of --. Notably, Ion Beam Applications SA's price-to-earnings ratio is 24.33x while UCB SA's PE ratio is 37.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ion Beam Applications SA is 0.82x versus 8.52x for UCB SA. Usually stocks with elevated PS ratios are considered overvalued.